A shorter DFS was determined for patients with higher expression of DUSP16 (log-rank test, p = 0.042), suggesting that there may be an association between higher DUSP16 expression and poor survival of HNSCC patients (Fig. 7D). The gene discussed is DUSP16; the disease is head and neck squamous cell carcinoma.